RxDoctor Payments Data

Craig Wiener, MD

Obstetrics & Gynecology · Paramus, NJNPI 1801886148

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $8,873 of the $12,605 with a category attached, or 70.4%. It is spread thinly across 60 manufacturers, the largest accounting for just 12.7%. Reporting peaked in 2019 at $3,646 and has fallen 63.4% since, to $1,335 in 2025. Among obstetrics & gynecology clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$12,605in general payments, 2019–2025

Across 577 payments — averaging $21.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Minerva Surgical, Inc$2K
  • AbbVie$1K
  • Momentis Surgical Inc.$968
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$768
  • Celularity Inc.$600
  • Novo Nordisk$530
  • plus $7K from 54 others

What the payments were for

  • Consulting fees$500%
  • Speaking & faculty fees$2,10017%
  • Travel & lodging$1,1489%
  • Food & beverage$8,87370%
  • Education$4343%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Minerva Surgical, Inc3$1,605
AbbVie(2 entities)128$1,415
Momentis Surgical Inc.3$968
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC54$768
Celularity Inc.2$600
Novo Nordisk35$530
Pfizer31$522
Astellas Pharma US Inc21$522
Asensus Surgical, Inc.7$473
Millicent US Inc26$405
Mayne Pharma Commercial LLC25$365
Hologic Sales And Service, LLC7$351
Exeltis, USA Inc.21$310
Therapeuticsmd, Inc.16$224
Sumitomo Pharma America, Inc.13$221
Radius Health, Inc.12$183
Sage Therapeutics, LLC10$182
Teva Pharmaceuticals USA, Inc.12$176
Takeda Pharmaceuticals U.S.A., Inc.12$175
Medtronic3$168
Baxter Healthcare1$144
Amgen9$140
Exact Sciences6$135
Evofem Biosciences, Inc.8$121
IBSA Pharma Inc.8$120
Currax Pharmaceuticals LLC8$119
Agile Therapeutics, Inc.8$117
Lilly USA, LLC7$113
Integra Lifesciences Corporation2$90
Merz North America, Inc.1$80
Myovant Sciences Inc.5$71
Vivus LLC5$70
Lundbeck LLC4$70
Avion Pharmaceuticals5$65
Bayer3$60
Urovant Sciences Inc4$58
Mission Pharmacal Company4$55
Ironwood Pharmaceuticals, Inc4$54
Vertical Pharmaceuticals, LLC4$54
Duchesnay USA Incorporated4$53
Convatec Inc.2$44
Avanos Medical2$44
Mimedx Group, Inc.1$44
Dysis Medical, Inc.2$43
Mycovia Pharmaceuticals, Inc.2$42
Axonics, Inc.2$41
Supernus Pharmaceuticals, Inc.2$34
Samsung HME America, Inc.1$30
Nalpropion Pharmaceuticals LLC2$29
QOL Medical, LLC2$29
Kerecis Limited1$28
Lupin Inc.2$28
Channel Medsystems, Inc.2$27
Smith+Nephew1$21
Aspira Women's Health Inc1$18
Optumhealth Care Solutions, LLC1$18
BD1$17
Ascend Therapeutics US, LLC1$15
Shire North American Group Inc1$14
Vanda Pharmaceuticals Inc.1$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,605 in reported general payments places this provider in the 95th percentile of 1,242 obstetrics & gynecology providers in New Jersey.

See all obstetrics & gynecology providers in New Jersey

Medicare billing

Part B allowed, 2024
$46,427
Medicare patients
96
Services billed
434

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
PremarinEstrogens, Conjugated16$10,464
Estradiol39$4,061
Raloxifene Hcl33$2,682
BijuvaEstradiol/Progesterone11$2,549
Sumatriptan12$1,758

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerPremarin$522$10,46416 claims
Therapeuticsmd, Inc.Bijuva$224$2,54911 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,242 obstetrics & gynecology providers in New Jersey.

Other obstetrics & gynecology in Paramus

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →